Nt1383 was located in the negative regulation domain of HBx (aa 1–50), and this 1383C mutation was first found to be associated with HCC in a Korean cohort and later was found to be able to induce a higher NF-kB activity in transformed cells [14,15]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.